Reply to Amit Bansal, Ruchir Maheshwari, and Anant Kumar's Letter to the Editor re: Beatriz Goulao, Sonya Carnell, Jing Shen, et al. Surgical Treatment for Recurrent Bulbar Urethral Stricture: A Randomised Open-label Superiority Trial of Open Urethroplasty Versus Endoscopic Urethrotomy (the OPEN Trial). Eur Urol 2020;78:572-80

被引：0

作者：

Vale, Luke ^{[1
]}

Goulao, Beatriz ^{[2
]}

MacLennan, Graeme ^{[3
]}

Watkin, Nick ^{[4
]}

机构：

[1] Newcastle Univ, Inst Hlth & Soc, Baddiley Clark Bldg,Richardson Rd, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England

[2] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland

[3] Univ Aberdeen, Ctr Healthcare & Randomised Trials, Aberdeen, Scotland

[4] St Georges Univ Hosp NHS Fdn Trust, London, England

来源：

EUROPEAN UROLOGY | 2021年 / 79卷 / 01期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1016/j.eururo.2020.10.021

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E24 / E25

页数：2

共 10 条

[1] Re: Beatriz Goulao, Sonya Carnell, Jing Shen, et al. Surgical Treatment for Recurrent Bulbar Urethral Stricture: A Randomised Open-label Superiority Trial of Open Urethroplasty Versus Endoscopic Urethrotomy (the OPEN Trial). Eur Urol 2020;78:572-80
Bansal, Amit
Maheshwari, Ruchir
Kumar, Anant
[J]. EUROPEAN UROLOGY, 2021, 79 (01) : E22 - E23
[2] Re: Surgical Treatment for Recurrent Bulbar Urethral Stricture: A Randomised Open-label Superiority Trial of Open Urethroplasty Versus Endoscopic Urethrotomy (the OPEN Trial)
Elliott, Sean P.
[J]. EUROPEAN UROLOGY, 2021, 79 (04) : 552 - 552
[3] Re: Surgical Treatment for Recurrent Bulbar Urethral Stricture: A Randomised Open-Label Superiority Trial of Open Urethroplasty versus Endoscopic Urethrotomy (the OPEN Trial)
Elliott, Sean P.
[J]. JOURNAL OF UROLOGY, 2021, 205 (05): : 1507 - 1507
[4] Surgical Treatment for Recurrent Bulbar Urethral Stricture: A Randomised Open-label Superiority Trial of Open Urethroplasty Versus Endoscopic Urethrotomy (the OPEN Trial)
Goulao, Beatriz
Carnell, Sonya
Shen, Jing
MacLennan, Graeme
Norrie, John
Cook, Jonathan
McColl, Elaine
Breckons, Matt
Vale, Luke
Whybrow, Paul
Rapley, Tim
Forbes, Rebecca
Currer, Stephanie
Forrest, Mark
Wilkinson, Jennifer
Andrich, Daniela
Barclay, Stewart
Mundy, Anthony
N'Dow, James
Payne, Stephen
Watkin, Nick
Pickard, Robert
[J]. EUROPEAN UROLOGY, 2020, 78 (04) : 572 - 580
[5] SURGICAL TREATMENT FOR RECURRENT BULBAR URETHRAL STRICTURE: A RANDOMISED OPEN LABEL SUPERIORITY TRIAL OF OPEN URETHROPLASTY VERSUS ENDOSCOPIC URETHROTOMY (THE OPEN TRIAL)
Nick, Watkin
Goulao, Beatriz
Carnell, Sonya
Jing, Shen
MacLennan, Graeme
Norrie, John
Cook, Jonathan
McColl, Elaine
Breckons, Matthew
Vale, Luke
Forbes, Rebecca
Currer, Stephanie
Forrest, Mark
Wilkinson, Jennifer
Andrich, Daniela
Barclay, Stewart
Munday, Anthony
N'Dow, James
Payne, Steve
Pickard, Robert
[J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E389 - E389
[6] Reply to Amit Bansal, Ruchir Maheshwari, and Anant Kumar's Letter to the Editor re: Fredrik Liedberg, Petter Kollberg, Marie Allerbo, et al. Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh: A Randomised Study. Eur Urol 2020;78:757-63
Liedberg, Fredrik
Kollberg, Petter
Allerbo, Marie
Baseckas, Gediminas
Brandstedt, Johan
Gudjonsson, Sigurdur
Hagberg, Oskar
Hakansson, Ulf
Jerlstrom, Tomas
Lofgren, Annica
Patschan, Oliver
Sorenby, Anne
Blackberg, Mats
[J]. EUROPEAN UROLOGY, 2021, 79 (03) : E79 - E80
[7] Reply to Riccardo Lombardo, Sara Riolo, and Cosimo De Nunzio's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. 2023;6:508-515
D'Andrea, David
Soria, Francesco
Hurle, Rodolfo
Enikeev, Dmitry
Kotov, Sergey
Regnier, Sophie
Xylinas, Evanguelos
Lusuardi, Lukas
Heidenreich, Axel
Cai, Chao
Frego, Nicola
Taraktin, Mark
Ryabov, Maxim
Gontero, Paolo
Comperat, Eva
Shariat, Shahrokh F.
[J]. EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (04): : 967 - 968
[8] Reply to Fabio Campodonico, Francesca Mattioli, and Carlo Introini's Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.08.003
Tan, Wei Shen
Kelly, John D.
HIVEC-II Trial Team
[J]. EUROPEAN UROLOGY, 2023, 83 (01) : E29 - E30
[9] Reply to Suman Sahoo, Abhishek Pandy, Swarnendu Mandal, Manoj Kumar Das, and Prasant Nayak's Letter to the Editor re: Wei Shen Tan, Aaron Pendergast, Charlotte Ackerman, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo. 2022.08.003
Tan, Wei Shen
Mustard, Connor
Kelly, John D.
[J]. EUROPEAN UROLOGY, 2023, 83 (02) : E48 - E49
[10] Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol 2023;6:508-15 Reply
D'Andrea, David
Soria, Francesco
Hurle, Rodolfo
Enikeev, Dmitry
Kotov, Sergey
Regnier, Sophie
Xylinas, Evanguelos
Lusuardi, Lukas
Heidenreich, Axel
Cai, Chao
Frego, Nicola
Taraktin, Mark
Ryabov, Maxim
Gontero, Paolo
Comperat, Eva
Shariat, Shahrokh F.
[J]. EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (03): : 639 - 640

← 1 →